<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Applied neuroimaging on Jordan Dworkin</title>
    <link>https://jordandworkin.com/tags/applied-neuroimaging/</link>
    <description>Recent content in Applied neuroimaging on Jordan Dworkin</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en</language>
    <lastBuildDate>Fri, 22 Apr 2022 00:00:00 +0000</lastBuildDate><atom:link href="https://jordandworkin.com/tags/applied-neuroimaging/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Statistical methods for diagnosis and screening using neuroimaging data</title>
      <link>https://jordandworkin.com/research/neuroimaging/</link>
      <pubDate>Fri, 22 Apr 2022 00:00:00 +0000</pubDate>
      
      <guid>https://jordandworkin.com/research/neuroimaging/</guid>
      <description>White matter lesions in multiple sclerosis Multiple sclerosis (MS) is a chronic disease of the central nervous system, characterized by progressive cognitive and motor disability. The high financial burden of MS treatments, and their heterogeneity in efficacy across patients, makes the detection of clinical biomarkers a vital goal in MS research. The presence of robust biomarkers could facilitate better individualization of care, allow for more efficient clinical trials, and even provide predictive insight into patientsâ€™ likely disease courses.</description>
    </item>
    
  </channel>
</rss>
